Search

everythinglearnresearchcommunity

for

Search:↓

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Developing human skin has immune cells with memory-like features.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The assay effectively identifies compounds that affect immune cell activation.

Alopecia areata involves unique activation of certain immune cells.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

The document suggests using convalescent plasma to treat COVID-19 Long Hauler Syndromes because it may contain beneficial elements that target the virus.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Chikungunya virus often causes skin issues and inflammation.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Enhancing Tregs can protect against alopecia areata.

Targeted immune modulation can help achieve stable remission in alopecia areata.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Clonally expanded CD8+ T cells cause alopecia areata.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Higher levels of IL-1a and IL-1RA were found in severe alopecia areata cases.

UV light helped human hair transplants survive in mice without broad immunosuppression.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

TNF-alpha inhibitors can cause various immune-related skin issues.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.